Eija Nissilä (E Nissilä)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 5

Top Topics

Ulcerative Colitis

Binding Protein

Chronic Kidney Disease

Mild Cognitive Impairment

Top Venues

Journal of Crohn's & colitis

Clinical and experimental immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Larisa Chernyaeva, Giorgio Ratti, Laura Teirilä, Satoshi Fudo, Uni Rankka, Anssi Pelkonen, Paula Korhonen, Katarzyna Leskinen, Salla Keskitalo, Kari Salokas, Christina Gkolfinopoulou, Katrina E Crompton, Matti Javanainen, Lotta J Happonen, Markku Varjosalo, Tarja Malm, Ville Leinonen, Angeliki Chroni, Päivi Saavalainen, Seppo Meri, Tommi Kajander, Adam J M Wollman, Eija Nissilä, Karita Haapasalo
Reduced binding of apoE4 to complement factor H promotes amyloid-β oligomerization and neuroinflammation. EMBO reports (2023)
Miikka Höyhtyä, Katri Korpela, Schahzad Saqib, Sofia Junkkari, Eija Nissilä, Anne Nikkonen, Evgenia Dikareva, Anne Salonen, Willem M de Vos, Kaija-Leena Kolho
Quantitative Fecal Microbiota Profiles Relate to Therapy Response During Induction With Tumor Necrosis Factor α Antagonist Infliximab in Pediatric Inflammatory Bowel Disease. Inflammatory bowel diseases (2022)
Rebecka Ventin-Holmberg, Anja Eberl, Schahzad Saqib, Katri Korpela, Seppo Virtanen, Taina Sipponen, Anne Salonen, Päivi Saavalainen, Eija Nissilä
Bacterial and Fungal Profiles as Markers of Infliximab Drug Response in Inflammatory Bowel Disease. Journal of Crohn's & colitis 15 (6) (2021)
Eija Nissilä, François P Douillard, Jarmo Ritari, Lars Paulin, Hanna M Järvinen, Pia Rasinkangas, Karita Haapasalo, Seppo Meri, Hanna Jarva, Willem M de Vos
Genotypic and phenotypic diversity of Lactobacillus rhamnosus clinical isolates, their comparison with strain GG and their recognition by complement system. PloS one 12 (5) (2017)
Eija Nissilä, K Korpela, A I Lokki, R Paakkanen, S Jokiranta, W M de Vos, M-L Lokki, K-L Kolho, S Meri
C4B gene influences intestinal microbiota through complement activation in patients with paediatric-onset inflammatory bowel disease. Clinical and experimental immunology 190 (3) (2017)